Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global Payments Inc (GPN) vs Humana Inc (HUM) Price & Performance

Global Payments IncTrade
Humana IncTrade

Price performance (Past 24H)

Key statistics

Global Payments Inc vs Humana Inc — how do they compare? Global Payments Inc trades at $82.55 (market cap $21.46B), while Humana Inc trades at $427.26 (market cap $46.49B). The key difference: Humana Inc is far larger — about 2.2× Global Payments Inc's market cap, and Global Payments Inc pays the higher dividend (1.23%). Which is the better fit depends on your goals — on Pluang, investors hold Global Payments Inc for 50 Days and Humana Inc for 51 Days on average.

GPNHUM
Market Cap
$21.46B$46.49B
Volume
1,482,6002,567,704
Sector
FinancialsHealth
52-Week High
$94.83$409.85
52-Week Low
$62.47$163.67
Typical Hold Time
50 Days51 Days
Enterprise Value
$39.60B$53.84B
Dividend Yield
1.23%0.91%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global Payments Inc

Global Payments (GPN) trades at $82.20, up 1.38% on the day, with a neutral technical signal and bullish moving averages. The stock has beaten EPS estimates for three consecutive quarters, though Q3 2026 results are pending. Revenue declined to $7.71B in 2025, but net income margin improved to 18.16%. Analyst consensus is bullish with a $102.75 price target, representing significant upside. Recent news highlights growth initiatives like the Genius platform and Worldpay integration.

GPN offers potential upside based on strong analyst sentiment and strategic initiatives, but faces risks from rising costs, high debt levels, and competitive pressures. The negative net income margin projection for 2026 underscores execution challenges. Investors should weigh the company's digital payment growth against macroeconomic and operational headwinds.

Humana Inc

Humana (HUM) trades at $436.00, up 9.96% in the last 24 hours, with a bullish technical signal and strong earnings beats in recent quarters. Revenue has grown to $129.66 billion in 2025, though net income margin compressed to 0.88%. Analyst consensus is a buy with a $457.05 price target, and recent news highlights a Barclays upgrade and dividend declaration.

The outlook is positive given earnings momentum and institutional interest, but risks include margin pressure and regulatory scrutiny. Upside potential exists if the company maintains enrollment growth and cost controls, though investors should monitor Medicare Advantage plan changes and competitive dynamics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GPN

No sentiment data available yet.

HUM
93% Buy7% Sell
Avg holding period · 51 Days

Top news

Latest headlines on both assets

About Global Payments Inc

Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares.

Read more on GPN →

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM →